JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on March 26, 2004
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
279/13/12369    most recent
M308908200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dinadayala, P.
Right arrow Articles by Daffé, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dinadayala, P.
Right arrow Articles by Daffé, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print January 10, 2004
J. Biol. Chem, 10.1074/jbc.M308908200
Submitted on August 12, 2003
Revised on January 9, 2004
Accepted on January 9, 2004

Revisiting the structure of the anti-neoplastic glucans of mycobacterium bovis bacille calmette-guomicron rin analysis of the different types of glucans produced by the vaccine substrains

Premkumar Dinadayala, Anne Lemassu, Pierre Granovski, Stéphane Cérantola, Nathalie Winter, and Mamadou Daffé

Molecular Mechanisms of Mycobacterial Infections, Institut de Pharmacologie et Biologie Structurale, Toulouse 31077

Corresponding Author: daffe{at}ipbs.fr

The attenuated strain of Mycobacterium bovis, Bacille Calmette-Guérin (BCG), used worldwide to prevent tuberculosis and leprosy is also clinically used as an immunotherapeutic agent against superficial bladder cancer. An anti-tumor polysaccharide has been isolated from the boiling-water extract of the Tice substrain of BCG and tentatively characterized as consisting primarily of repeating units of 6-linked-glucosyl residues. M. tuberculosis and other mycobacterial species produce a glycogen-like alpha-glucan, composed of repeating units of 4-linked-glucosyl residues substituted at some positions 6 by short oligoglucosyl units, that also exhibits an anti-tumor activity. Therefore, the impression prevails that mycobacteria synthesize different types of anti-neoplastic glucans or, alternatively, the BCG substrains are singular in producing a unique type of glucan that may confer to them their immunotherapeutic property. The present study addresses this question through the comparative analysis of alpha-glucans purified from the extracellular materials and boiling-water extracts of three vaccine substrains. The polysaccharides were purified and their structural features were established by mono-and two-dimensional NMR spectroscopy and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of the enzymatic and chemical degradation products of the purified compounds. The glucans isolated by the two methods from the three substrains of BCG were shown to exhibit identical structural features shared with the glycogen-like alpha-glucan of M. tuberculosis and other mycobacteria. Incidentally, we observed an occasional release of dextrans from Sephadex columns that may explain the reported occurrence of 6-substituted-alpha-glucans in mycobacteria.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
GlycobiologyHome page
P. Dinadayala, T. Sambou, M. Daffe, and A. Lemassu
Comparative structural analyses of the {alpha}-glucan and glycogen from Mycobacterium bovis
Glycobiology, July 1, 2008; 18(7): 502 - 508.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Stadthagen, T. Sambou, M. Guerin, N. Barilone, F. Boudou, J. Kordulakova, P. Charles, P. M. Alzari, A. Lemassu, M. Daffe, et al.
Genetic Basis for the Biosynthesis of Methylglucose Lipopolysaccharides in Mycobacterium tuberculosis
J. Biol. Chem., September 14, 2007; 282(37): 27270 - 27276.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
S. Berg, D. Kaur, M. Jackson, and P. J Brennan
The glycosyltransferases of Mycobacterium tuberculosis--roles in the synthesis of arabinogalactan, lipoarabinomannan, and other glycoconjugates
Glycobiology, June 1, 2007; 17(6): 35R - 56R.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Yadav and J. S. Schorey
The beta-glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria
Blood, November 1, 2006; 108(9): 3168 - 3175.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. C. B. Bittencourt, R. T. Figueiredo, R. B. da Silva, D. S. Mourao-Sa, P. L. Fernandez, G. L. Sassaki, B. Mulloy, M. T. Bozza, and E. Barreto-Bergter
An {alpha}-Glucan of Pseudallescheria boydii Is Involved in Fungal Phagocytosis and Toll-like Receptor Activation
J. Biol. Chem., August 11, 2006; 281(32): 22614 - 22623.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
R. E.B. Lee, W. Li, D. Chatterjee, and R. E. Lee
Rapid structural characterization of the arabinogalactan and lipoarabinomannan in live mycobacterial cells using 2D and 3D HR-MAS NMR: structural changes in the arabinan due to ethambutol treatment and gene mutation are observed
Glycobiology, February 1, 2005; 15(2): 139 - 151.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.